Global POCT Molecular Diagnostics Technology Market Growth (Status and Outlook) 2025-2031
The global POCT Molecular Diagnostics Technology market size is predicted to grow from US$ 6201 million in 2025 to US$ 10980 million in 2031; it is expected to grow at a CAGR of 10.0% from 2025 to 2031.
Molecular POCT refers to a molecular biology detection system that is fully automated and integrated through technological innovation and optimization to meet the requirements of point-of-care testing (POCT). This system is an integrated closed system, and its nucleic acid extraction and amplification detection are all completed on the same closed, portable instrument, without the need for manual preparation of reagents or manual sample processing. No other manual operations are required from the time the sample is loaded on the machine to the result report, which can effectively prevent biological samples and their genetic materials from polluting the environment. It also has the characteristics of miniaturization, easy to carry, automation, full closure, fast speed, and easy operation.
Key Features:
- High specificity and sensitivity
- Suitable for various inspection scenarios
- Rapid and accurate detection
Segmentation by Type:
- Reagents Consumables
- Equipment
- Other
Segmentation by Application:
- Hospital
- Decentralized Laboratory
- Other
Market by Region:
- Americas
- APAC
- Europe
- Middle East & Africa
Company Coverage:
- Danaher (Cepheid)
- Roche
- Abbott
- bioMérieux
- Hologic
- Thermo Fisher Scientific
- Bohui Innovation
- AoBio
- Shengxiang Bio
- Kayoudi
- Hangzhou Yousda
Key Questions Addressed in this Report:
Frequently Asked Questions
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market